The results showed that only the upregulation of PVT1 (upstream lncRNA of hsa-miR-16-5p) (Fig. 6D, P < 0.05) had a worse prognosis in patients with PAAD (P = 0.041). The gene discussed is PVT1; the disease is pancreatic adenocarcinoma.